GATA3 and primary cutaneous T-cell non-Hodgkin lymphoma: Compared with previous reports (32), we did not observe significant differences in the levels of GATA-3 in CD4+ T cells from CTCL lesions compared with CS, but its expression was significantly lower in CTCL lesions than in AD lesions.